Gastroenterology & Hepatology
These journals cover all medical and surgical aspects of GI and liver care – both scientific and clinical.
Related journals you may be interested in:
Recent articles:
Efficacy and Safety of Modified Sishen Decoction for Tyrosine Kinase Inhibitor-Induced Diarrhea in Hepatocellular Carcinoma: A Randomized Controlled Trial
Cao J, He S, Yu S, Shen J, Hu N, Yu D, Cao T, Jiang L, Peng J, Zhai X
Journal of Hepatocellular Carcinoma 2026, 13:608479
Published Date: 9 July 2026
Correlation of Insulin and/or Insulin Secretagogues with the Risk of Hepatocellular Carcinoma and All-Cause Mortality Among Patients with Chronic Hepatitis B and Type 2 Diabetes Mellitus: A Retrospective Cohort Study
Zhou M, Zhou P, Xu W, Zhu D, Zhang F, Li W, Ye C
Journal of Hepatocellular Carcinoma 2026, 13:611091
Published Date: 9 July 2026
SPP1+ Macrophages Promote Immunosuppression in Post-TACE Hepatocellular Carcinoma Involving Lactate-Induced Lactylation and Potential SPP1-CD44 Signaling
Wang H, Liang G, Liu T, He M, Jiang Y, Li J, Ouyang Y, Hao S, Liu W, Li J
Journal of Hepatocellular Carcinoma 2026, 13:603485
Published Date: 8 July 2026
Etiology-Driven Mouse Models of Hepatocellular Carcinoma: Paving the Way for Precision Oncology
Cao W, Fan Y, Chen H, Sun J, Jin X
Journal of Hepatocellular Carcinoma 2026, 13:621043
Published Date: 8 July 2026
Preoperative Prediction of Glypican-3 Expression in Hepatocellular Carcinoma Using Sonazoid Contrast-Enhanced Ultrasound Radiomics
Yang S, Huang Z, Zheng W, Li L, Xue Y, Zou R, Peng C
Journal of Hepatocellular Carcinoma 2026, 13:610969
Published Date: 30 June 2026
Baseline Sleep Quality and Objective Response in HCC Patients Treated with TACE Combined with Lenvatinib and PD-1 Inhibitors: A Secondary Analysis of a Prospectively Registered Observational Cohort
Tian P, Zhao H, Sun W, Peng Q, Luo Y, Sang M, Xi J, Song HY, Yang Z
Journal of Hepatocellular Carcinoma 2026, 13:600627
Published Date: 29 June 2026
Emerging Role of Sirtuins-Mediated Ferroptosis in Hepatocellular Carcinoma Progression: Mechanisms and Therapeutic Perspectives
Bai J, Bai X, Yang J, Yu G, Cui Y
Journal of Hepatocellular Carcinoma 2026, 13:595693
Published Date: 29 June 2026
Machine-Learning Based Prognostic Model for Predicting Early Recurrence in HCC Patients After Hepatectomies: An Explainable AI Approach
Hsu HY, Lin JC, Huang CW, Huang SF, Wu CY, Huang TS, Lai HF, Yu MC
Journal of Hepatocellular Carcinoma 2026, 13:618264
Published Date: 24 June 2026
Angiogenic Prognostic Signature for Stratification in Hepatocellular Carcinoma
Zhu Z, Guo C, Shen H, Zeng S, Li N
Journal of Hepatocellular Carcinoma 2026, 13:600117
Published Date: 20 June 2026
Multimodal Modeling Distinguishes Treatment Response from Overall Survival in Hepatocellular Carcinoma Receiving Combined Interventional and Targeted Immunotherapy
Lu D, Sun P, Li H, Liang Z, Zhang Z, Cao Q, Zhang D, He Q, Jia J, Wang Y, Dong Z, Wang D, Li T
Journal of Hepatocellular Carcinoma 2026, 13:613014
Published Date: 20 June 2026
Integrating Combination Therapy and Smart Embolic Materials to Overcome the Therapeutic Ceiling of Transarterial Chemoembolization in Hepatocellular Carcinoma
Fu Y, Bai C, Ling Y, Liu Y, Li W, Li G
Journal of Hepatocellular Carcinoma 2026, 13:620956
Published Date: 19 June 2026
Current Status and Emerging Trends in Global Research on Liposome Therapy for Hepatocellular Carcinoma: A Bibliometric Analysis
Hong X, Wu Y, Wu X, Huang C, Li C
Journal of Hepatocellular Carcinoma 2026, 13:608648
Published Date: 19 June 2026
Machine Learning-Based Radiopatho-Clinical Model Integrating Ultrasound Radiomics and Kleiner Score for Prognosis Prediction in NAFLD-Related Hepatocellular Carcinoma
Li CL, Jia Z, Yao ZY, Cui XT, Sun A, Hao AY, Chen ZY, Chen F, Cao JY, Wang ZS
Journal of Hepatocellular Carcinoma 2026, 13:611041
Published Date: 19 June 2026
A Machine Learning Guided System for Therapeutic Decision-Making in Intra-Arterial Therapy of Hepatocellular Carcinoma
Tan L, Fan R, Zhang J, Fan H, Wu S, Li W
Journal of Hepatocellular Carcinoma 2026, 13:613199
Published Date: 18 June 2026
Putative Imprinting Control Regions with Aberrant Blood-Based DNA Methylation are Associated with Hepatocellular Carcinoma Risk
DiFrank AJ, Corliss BA, Park JJH, Rogers M, Skaar DA, Jima DD, Cowley M, Murphy SK, Liu A, Moylan CA, Hoyo C
Journal of Hepatocellular Carcinoma 2026, 13:605131
Published Date: 18 June 2026
Hepatocellular Carcinoma Precursor Lesions: From Pathological Basis to Risk Stratification and Precision Intervention
Yan R, Zhang H, Jiao J, Huang Q, Wang N, Bao J, Li X, Yan S, Li J
Journal of Hepatocellular Carcinoma 2026, 13:613101
Published Date: 18 June 2026
TACE Combined with Ralox-HAIC (Oxaliplatin Puls Raltitrexed) and System Therapy in Patients with Unresectable Hepatocellular Carcinoma
Liu R, Cao G, Li L, Liu J, Cao H, Xing M, Feng Y, Li Z, Wang B
Journal of Hepatocellular Carcinoma 2026, 13:609273
Published Date: 18 June 2026
Intratumoral Fibrosis is a Potential Biomarker in Patients with Hepatocellular Carcinoma Undergoing Liver Resection
Deng QY, Wang TC, Ye K
Journal of Hepatocellular Carcinoma 2026, 13:608858
Published Date: 18 June 2026
Near-Infrared Fluorescent Probes Targeting LAG-3 for Guiding Immunomodulation and Efficacy Monitoring of Stereotactic Body Radiotherapy in Liver Cancer
Lu Q, Zeng P, An Y, Qin Y, Zhang J, Xu M, Wang C, Wu M, Chen R
Journal of Hepatocellular Carcinoma 2026, 13:584426
Published Date: 17 June 2026
Prognostic Value of the SEA Score in Double-Negative DCP/AFP Unresectable HCC with Triple Therapy
Lin H, Ran F, Wu J, Huang C, Wu J, Liu C, Wang X, Ya H, Jiang K, Gu J, Yan M, Li S
Journal of Hepatocellular Carcinoma 2026, 13:606282
Published Date: 16 June 2026
A Novel Predictive Model Based on Glutathione Metabolism Genes RRM2 and G6PD in Hepatocellular Carcinoma
Li X, Tang J, Qin H, Huang Y, Li M, Yang Z, Meng J, Li L
Journal of Hepatocellular Carcinoma 2026, 13:529380
Published Date: 16 June 2026
Development and Validation of a Machine Learning-Based Individualized Model to Predict TKI Benefit in Postoperative Recurrent HCC
Li M, Jiang Y, Gong L, Sun R, Hao A, Liu K, Luan K, Jia Z, Zhang S, Liu K, Tan B, Hu W, Qu C, Cao J
Journal of Hepatocellular Carcinoma 2026, 13:599142
Published Date: 16 June 2026
Tumor-Associated Macrophages in Hepatocellular Carcinoma: From Ontogeny and Heterogeneity to Immune Evasion and Therapeutic Targeting
Su Y, Liang Y, Zhong D, Chen Y, Ma SS, Huang X
Journal of Hepatocellular Carcinoma 2026, 13:616101
Published Date: 16 June 2026
Subgroup-Specific Nomogram for Refined Risk Stratification in Hepatocellular Carcinoma Patients with Low LDL-C
Liu B, Gu Z, Li L, Li L, Jin R, Hu C
Journal of Hepatocellular Carcinoma 2026, 13:616354
Published Date: 15 June 2026
Comparative Performance of Stereotactic Body Radiotherapy and Lenvatinib in Unresectable Hepatocellular Carcinoma Complicated by Portal Vein Tumor Thrombosis: A Propensity Score-Matched Cohort Analysis
Huang J, Liu FC, Yang Y, Yuan SX, Gu FM, Jiang BG, Pan ZY
Journal of Hepatocellular Carcinoma 2026, 13:589137
Published Date: 15 June 2026
Aberrant Cholesterol Metabolism Caused by Decreased Lecithin: Cholesterol Acyltransferase Promoted Hepatocarcinogenesis
Gao H, Peng X, Wen Y, Gou L, Xu Y, Qu X, Wu J, Xue B
Journal of Hepatocellular Carcinoma 2026, 13:562838
Published Date: 15 June 2026
Transarterial Chemoembolization in Hepatocellular Carcinoma: Lessons from a 10-Year Real-World Retrospective Study
von Schoen-Angerer G, Pesola G, Garo ML, Marini G, Cappio S, Cerny A, Magenta L, Majno-Hurst P, Bernardi L, Cefalì M, Cristaudi A, Terziroli Beretta-Piccoli B, Trevisi E, De Dosso S
Journal of Hepatocellular Carcinoma 2026, 13:598858
Published Date: 15 June 2026
Optimizing Hepatocellular Carcinoma Selection for Liver Transplantation: The Impact of an Integrated MELD-ALBI Score on Post-Transplant Outcomes
Alkhatib A, Gomaa AI, Abdel-Razek W
Journal of Hepatocellular Carcinoma 2026, 13:614920
Published Date: 12 June 2026
Development and Validation of a Nomogram Predictive Model for Massive Ascites After Hepatectomy in Patients with Primary Hepatocellular Carcinoma
Men A, Sun D, Sun X, Jin L, Liu B, Chen F, Nan B, Wang W, Han L, Zhang W
Journal of Hepatocellular Carcinoma 2026, 13:610812
Published Date: 11 June 2026
Low Tumor miR-369-3p Levels Combined with Plasma Hepatitis B Virus Pre-S2 Gene Deletion Mutation Predict Higher Hepatocellular Carcinoma Recurrence
Wu YC, Jeng LB, Li TC, Wang J, Teng CF
Journal of Hepatocellular Carcinoma 2026, 13:591511
Published Date: 10 June 2026
Comparable Long-Term Survival After Curative Hepatectomy for Solitary Large (5–10 cm) versus Giant (≥10 cm) Hepatocellular Carcinoma: A Retrospective Study
Jiang K, Li J, Zhang D, Wang W, Chang J
Journal of Hepatocellular Carcinoma 2026, 13:607722
Published Date: 8 June 2026
Post-Treatment Prognostic Nutritional Index Outperforms Baseline Index as an Independent Prognostic Biomarker in Advanced Hepatocellular Carcinoma Receiving Immune-Based Systemic Therapy
Chen X, Guo X, Wang M, Chen G, Zheng S, Chen H, Zhang Z, Zhang B
Journal of Hepatocellular Carcinoma 2026, 13:606554
Published Date: 8 June 2026
Gut Microbiome and Short-Chain Fatty Acid Alterations After Cardiopulmonary Bypass are Associated with Nutritional and Functional Impairment in Young Children with Congenital Heart Defects
Agzamova SA, Babadjanova FR
Clinical and Experimental Gastroenterology 2026, 19:600414
Published Date: 8 June 2026
Impact of Microwave Ablation on Growth Kinetics of Residual versus Synchronous Untreated Hepatocellular Carcinoma: A Retrospective Cohort Study
Yi W, Pang C, Xue J, Zhang Y, Chen X, Luo T, Zhang D, Gao X, Yu J, Liang P
Journal of Hepatocellular Carcinoma 2026, 13:603442
Published Date: 4 June 2026
When Resectability Emerges After Systemic Therapy in Hepatocellular Carcinoma: A Proposed Response-Guided Consolidation Framework
Cheng Y, Xie K
Journal of Hepatocellular Carcinoma 2026, 13:613934
Published Date: 4 June 2026
Irritable Bowel Syndrome Prevalence in Patients with Inflammatory Bowel Disease in Remission: Single-Center Experience
Golubovic O, Knezevic Ivanovski T, Kralj D, Mitrovic M, Milić A, Svorcan P, Markovic S
Clinical and Experimental Gastroenterology 2026, 19:582517
Published Date: 3 June 2026
Histone Methylation: A Pivotal Epigenetic Driver of the Malignant Transformation of MASLD-HCC
Zhang Y, Chen T, Chang Z, Qi X, Yan R, Zhang H, Guan X, Yan S, Li J, Jiao J
Journal of Hepatocellular Carcinoma 2026, 13:598429
Published Date: 3 June 2026
Rare Long-Term Transformation from Solitary Hepatocellular Carcinoma to Synchronous Double Primary Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: A Case Report and Literature Review
Qiao L, Wei P, Lo C, Luo Y, Peng Y, Kang Z, Gao J, Zhu J, Li Z
Journal of Hepatocellular Carcinoma 2026, 13:598850
Published Date: 28 May 2026
Primary Colorectal Signet Ring Cell Carcinoma and the Risk of Multiple Primary Gastrointestinal Malignancies: A Retrospective Cohort Based on SEER Database from 2000-2021
Hamed BM, Ellaithy A, Alesawy AF, Alhusban A, Ali N, Al-Shaikh B, Elshennawy EM, Elbadry SA
Clinical and Experimental Gastroenterology 2026, 19:588726
Published Date: 27 May 2026
Efficacy of Locoregional HAIC and Systemic Treatment for Treatment- Naive Unresectable Hepatocellulcar Carcinoma
Chen M, Zhang L, Liu C, Xu X, Zhang J, Yuan J, Ge N, Chen Y, Xie X, Zhang L, Chen R
Journal of Hepatocellular Carcinoma 2026, 13:606458
Published Date: 27 May 2026
Decoding Treatment Response in Hepatocellular Carcinoma: The Era of Radiomics and Radiogenomics
Wang Z, Gan W, Gong J, Li X
Journal of Hepatocellular Carcinoma 2026, 13:595928
Published Date: 27 May 2026
Multimodal Conversion Therapy Enabling Curative Resection in Giant Hepatocellular Carcinoma with Arteriovenous Fistula: A Case Report
Zhong H, Tan L, Le W, Luo N, Shen Y, Long G, Xiong C, Tao H
Journal of Hepatocellular Carcinoma 2026, 13:599120
Published Date: 26 May 2026
Dynamic AFP-Defined Disease State Transitions in Hospitalized Patients with Hepatocellular Carcinoma Using the Multi-State Markov Model: A Retrospective Cohort Study
Song Q, Zhang H, Jia M, Yu Y, Jiang Y, Yuan J, Su S
Journal of Hepatocellular Carcinoma 2026, 13:603210
Published Date: 26 May 2026
HAIC Combined with Lenvatinib and Pembrolizumab for Unresectable Hepatocellular Carcinoma: A Retrospective Study
Liang J, Yang Z, Yang Z, Li H, Hong J, Pan Y, Fu Y, Wang J, Zhou Z, Zhang Y, Chen M, Chen J, Hu D
Journal of Hepatocellular Carcinoma 2026, 13:600557
Published Date: 26 May 2026
SR-HCC Score: A Novel Nomogram for Predicting Spontaneous Rupture in Hepatocellular Carcinoma Patients
Gao S, Zhang X, Jia T, Jin Q, Yang X, Zhao R, Gao J
Journal of Hepatocellular Carcinoma 2026, 13:600415
Published Date: 25 May 2026
Efficacy and Safety of TACE-HAIC Combined with Molecular Targeted Therapy and Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma
Feng Z, Wang X, Xu J, Chen S, Hao M, Hu H, Qiu S, Liao Y, Yu W, Fang Z
Journal of Hepatocellular Carcinoma 2026, 13:588860
Published Date: 22 May 2026
Development and Validation of a HAUS-Related Prognostic Signature in Liver Hepatocellular Carcinoma: A Multi-Omics Integration from Pan-Cancer Analysis to Single-Cell Resolution
Liu Y, Liu K, Ding Y, Li X, Shi X, Zhang J, Zhang X, Peng W, Deng J, Chen J
Journal of Hepatocellular Carcinoma 2026, 13:598179
Published Date: 22 May 2026
A Preoperative MRI-Based Score to Predict High-Risk Pathology and Stratify Adjuvant Therapy Benefit in BCLC 0/A Hepatocellular Carcinoma
Li H, Wang X, Yu C, Li B, Hu Z, Li W, Chen Y, Zhou Y, Sun Y
Journal of Hepatocellular Carcinoma 2026, 13:605420
Published Date: 22 May 2026
Post-Translational Modification Networks in Ferroptosis: Orchestrating Defense, Drug Resistance, and Therapeutic Opportunities in Hepatocellular Carcinoma
Chen J, Li L, Fang S, Zhou H
Journal of Hepatocellular Carcinoma 2026, 13:607656
Published Date: 21 May 2026
Determinants of Fear of Cancer Recurrence and Development of a Nomogram-Based Risk Prediction Model in Patients with Primary Liver Cancer: A Single-Center Cross-Sectional Study
Du J, Shi C, Zhang Y, Li J, Yang D
Journal of Hepatocellular Carcinoma 2026, 13:611163
Published Date: 21 May 2026